In Other Journals

Tanya Grassi
Med J Aust 2009; 191 (1): . || doi: 10.5694/j.1326-5377.2009.tb02677.x
Published online: 6 July 2009

Intestinal metaplasia of the oesophagus (Barrett’s oesophagus) is associated with an increased risk of oesophageal adenocarcinoma through the development of epithelial dysplasia. In a randomised controlled trial involving 127 patients, researchers in the United States have found that radiofrequency ablation of dysplastic Barrett’s oesophagus was successful in achieving a high rate of eradication of the abnormality, along with a reduced risk of disease progression. The authors caution that the results must be interpreted in relation to the grade of severity of oesophageal dysplasia, which has varying risk of progression to cancer. They also comment on potential side effects, including oesophageal stricture, and suggest the need for cost–benefit analyses.

  • Tanya Grassi



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.